Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Impact of halotherapy on COPD exacerbations

Victorita Mihaela Sandu, Traian Mihaescu, Dumitru Filipeanu, Andrei Cernomaz, Radu Adrian Crisan-Dabija
European Respiratory Journal 2019 54: PA2498; DOI: 10.1183/13993003.congress-2019.PA2498
Victorita Mihaela Sandu
1Clinic of Respiratory Diseases, Iasi, Romania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mihaelavsandu@hotmail.com
Traian Mihaescu
2University of Medicine and Pharmacy “Grigore Th Popa”, Iasi, Romania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dumitru Filipeanu
3Universitatea Tehnica “Gheorghe Asachi”, Iasi, Romania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrei Cernomaz
2University of Medicine and Pharmacy “Grigore Th Popa”, Iasi, Romania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Radu Adrian Crisan-Dabija
2University of Medicine and Pharmacy “Grigore Th Popa”, Iasi, Romania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Halotherapy is a well-known alternative treatment method used in rehabilitation of respiratory chronic diseases and prevention of pulmonary infectious diseases, having both empiric and scientific data for its success. Romania has the geographical opportunity of many areas enriched by salt springs and natural salt caves that provided the background for more elaborate studies regarding the benefits of halotherapy for patients with chronic respiratory diseases.

As shown in recent studies, patients with chronic obstructive pulmonary disease benefit most from sessions of halotherapy and with the help of recent technological progress, the cure can be obtained using small inhalers with pure salt.

We propose a retrospective study to assess the impact of daily home halotherapy sessions on reducing exacerbations on patients with stage II and III COPD using our clinic data.

A pool of 215 patients was selected from our clinic database (between 2016-2018) with stage II or III COPD. Using patients’ history and hospital presentations we assessed the number of hospital admissions due to COPD exacerbations and manually checked whether patients had a recommendation of halotherapy. Our study found that 28 patients had a halotherapy recommendation (13%). 65,6% of patients (142) had at least 2 exacerbation within the 3 years period and only 9 of them had a recommendation for halotherapy. 19 patients had no COPD exacerbations in the given period.

Halotherapy seems to have a positive impact on reducing the exacerbation risk of patients with chronic pulmonary diseases but has still a low rate of recommendation from the respiratory professionals due to their possible lack of trust in a method that doesn’t produce immediate effects.

  • COPD - management
  • Quality of life
  • Airway management

Footnotes

Cite this article as: European Respiratory Journal 2019; 54: Suppl. 63, PA2498.

This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).

  • Copyright ©the authors 2019
Previous
Back to top
Vol 54 Issue suppl 63 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Impact of halotherapy on COPD exacerbations
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Impact of halotherapy on COPD exacerbations
Victorita Mihaela Sandu, Traian Mihaescu, Dumitru Filipeanu, Andrei Cernomaz, Radu Adrian Crisan-Dabija
European Respiratory Journal Sep 2019, 54 (suppl 63) PA2498; DOI: 10.1183/13993003.congress-2019.PA2498

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Impact of halotherapy on COPD exacerbations
Victorita Mihaela Sandu, Traian Mihaescu, Dumitru Filipeanu, Andrei Cernomaz, Radu Adrian Crisan-Dabija
European Respiratory Journal Sep 2019, 54 (suppl 63) PA2498; DOI: 10.1183/13993003.congress-2019.PA2498
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Identifying super-responders to benralizumab in severe asthma
  • Utility of Interleukin-5 in phenotyping allergic versus non allergic asthma
  • Mepolizumab in the treatment of severe asthma with nasal polyposis: real-life study
Show more Airway pharmacology and treatment

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society